Go Pro

Helfey Hannah Analyst Performance

Analyst at Stephens

Helfey Hannah is a stock analyst at Stephens in the healthcare sector, covering 3 publicly traded companies. Over the past year, Helfey Hannah has issued 2 stock ratings, including and hold recommendations. While full access to Helfey Hannah's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Helfey Hannah's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
4 Last 1 Years
Buy Recommendations
50.00% 2 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%2 ratings
Hold50.0%2 ratings
Sell0.0%0 ratings

Out of 4 total stock ratings issued by Helfey Hannah at Stephens, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

Helfey Hannah, an analyst at Stephens, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
3 companies
100.0%

Helfey Hannah of Stephens specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
LIFE SCIENCES TOOLS & SERVICES
3 companies
100.0%

Helfey Hannah's Ratings History at Stephens

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
7/27/2026Reiterated Rating$30.11$31.00Equal Weight
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
7/27/2026Downgrade$29.79$31.00Equal Weight
MaxCyte, Inc. stock logo
MXCT
MaxCyte
7/22/2025Initiated Coverage$2.10$6.00Overweight
CryoPort, Inc. stock logo
CYRX
CryoPort
7/22/2025Initiated Coverage$6.87$13.00Overweight